GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (HAM:NOV) » Definitions » Shares Buyback Ratio %

Novo Nordisk A/S (HAM:NOV) Shares Buyback Ratio % : 0.80 (As of Jun. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Novo Nordisk A/S Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Novo Nordisk A/S's current shares buyback ratio was 0.80%.


Novo Nordisk A/S Shares Buyback Ratio % Historical Data

The historical data trend for Novo Nordisk A/S's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Shares Buyback Ratio % Chart

Novo Nordisk A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.04 2.08 1.70 2.60 0.92

Novo Nordisk A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.35 0.23 0.31 -0.08

Novo Nordisk A/S Shares Buyback Ratio % Calculation

Novo Nordisk A/S's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(4499.8 - 4458.29) / 4499.8
=0.92%

Novo Nordisk A/S's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Mar. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(4458.29 - 4461.91) / 4458.29
=-0.08%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novo Nordisk A/S Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk A/S (HAM:NOV) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S (HAM:NOV) Headlines

From GuruFocus

NOV Declares Regular Quarterly Dividend

By Business Wire Business Wire 05-18-2023

NOV Reports Second Quarter 2023 Earnings

By Business Wire 07-26-2023

Oldfield Partners LLP Buys NOV Inc, Sells SK Telecom Co, Ternium SA, Infosys

By GuruFocus Research GuruFocus Editor 02-08-2022

The NOV Inc (NOV) Company: A Short SWOT Analysis

By GuruFocus Research 10-30-2023

NOV Declares Regular Quarterly Dividend

By Business Wire 08-17-2023

NOV Appoints Robert Welborn to the Board of Directors

By Business Wire Business Wire 10-20-2021

NOV Inc's (NOV) Market Value: An In-Depth Analysis

By GuruFocus Research 10-04-2023

NOV Announces First Quarter 2022 Earnings Conference Call

By Business Wire Business Wire 03-18-2022